Cushing’s syndrome Archives

Corcept Therapeutics expands hypercortisolism evidence base with largest US resistant hypertension screening trial

By Pallavi Madhiraju on March 29, 2026 Medical Devices & Diagnostics

Corcept’s MOMENTUM trial finds hypercortisolism in 27.3% of resistant hypertension patients. Explore what this means for screening and treatment. Read more.

Corcept’s relacorilant CRL leaves endocrinology ambitions in limbo as oncology pivot takes center stage

By Pallavi Madhiraju on January 1, 2026 Pharma & Biotech

Find out why FDA’s complete response letter for Corcept’s relacorilant could reshape treatment of hypercortisolism, with implications for oncology approval.